ACORN BIOVENTURES
Our invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
ACORN BIOVENTURES
Founded:
2017-01-01
Status:
Active
Contact:
212 299-4770
Technology used in webpage:
U.S. Server Location
Similar Organizations
Cherrystone Angel Group
Providence based angel group interested in biopharma, medical device and tech startups in New England.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Rittenhouse Ventures
Rittenhouse Ventures provides capital & growth strategies with advanced software solutions for healthcare, financial and business services..
Current Employees Featured
Isaac Manke Partner @ Acorn Bioventures
Partner
2020-04-01
Anders Hove Partner & Founder @ Acorn Bioventures
Partner & Founder
2017-01-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-09 | Acrivon Therapeutics | Acorn Bioventures investment in Post-IPO Equity - Acrivon Therapeutics | 130 M USD |
| 2024-04-05 | Protara Therapeutics | Acorn Bioventures investment in Post-IPO Equity - Protara Therapeutics | 45 M USD |
| 2024-04-03 | Neurosterix | Acorn Bioventures investment in Series A - Neurosterix | 63 M USD |
| 2024-03-25 | Q32 Bio | Acorn Bioventures investment in Post-IPO Equity - Q32 Bio | 42 M USD |
| 2024-03-13 | Cybin | Acorn Bioventures investment in Post-IPO Equity - Cybin | 150 M USD |
| 2023-12-12 | Bicara Therapeutics | Acorn Bioventures investment in Series C - Bicara Therapeutics | 165 M USD |
| 2023-10-30 | VYNE Therapeutics | Acorn Bioventures investment in Post-IPO Equity - VYNE Therapeutics | 88 M USD |
| 2023-08-02 | CG Oncology | Acorn Bioventures investment in Series F - CG Oncology | 105 M USD |
| 2023-05-23 | OnKure Therapeutics | Acorn Bioventures investment in Series C - OnKure Therapeutics | 54 M USD |
| 2023-03-06 | Bicara Therapeutics | Acorn Bioventures investment in Series B - Bicara Therapeutics | 108 M USD |
More informations about "Acorn Bioventures"
Acorn Bioventures
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients.Our investment flexibility allows us …See details»
Acorn Bioventures - Crunchbase Investor Profile & Investments
Acorn Bioventures invests in late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy is concentrated in the United States, particularly in …See details»
Acorn Bioventures - Investments, Portfolio & Company Exits
Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies. Search Crunchbase. Start Free Trial . Chrome Extension. ... How many …See details»
Acorn Bioventures - LinkedIn
Acorn Bioventures Investment Management New York, NY 335 followers Investing in private and small capitalization biotech, specialty pharma and medical device companies.See details»
Acorn Bioventures investment portfolio - PitchBook
Acorn Bioventures General Information Company Description. Founded in 2017, Acorn Bioventures is a venture capital investment firm based in New York, New York. The firm seeks to invest in companies operating in the biotechnology, …See details»
Acorn Bioventures - Investor Profile, Portfolio & Team - Tracxn
Dec 26, 2024 11 of Acorn Bioventures' portfolio companies have become public. Bicara Therapeutics got listed on the National Association of Securities Dealers Automated …See details»
Acorn Bioventures Company Profile | Management and Employees …
Acorn Bioventures is structured to be able to provide committed capital to companies through multiple rounds of financing. Our investment process is based on fundamental research. We …See details»
Acorn Bioventures - Funding, Financials, Valuation & Investors
Acorn Bioventures has raised a total of $199.5M in a single venture fund, Acorn Bioventures. This fund was announced on Mar 7, 2019 and raised a total of obfuscatedSee details»
Acorn Bioventures LP - Company Profile and News
Acorn Bioventures, L.P. is as a venture capital firm. The Firm invests across stages in small-cap public and private biotechnology companies focuses on bringing novel innovative medicines to …See details»
Acorn Bioventures Investor Information - Funding, Portfolio …
Acorn Bioventures provides financial support to early-stage health-related businesses, particularly in biotechnology and health technology. They invest between $500k and $10M to assist in …See details»
Acorn Bioventures - VC Firm Profile - Gaebler.com Venture Capital …
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us …See details»
Acorn Bioventures - Company Profile & Staff Directory - ContactOut
Acorn Bioventures provides a range of services including strategic consulting, product development, and commercialization support for biotechnology and life sciences companies. …See details»
Acorn Bioventures – Investors Database – Unicorn Nest
Acorn Bioventures. SAVE. Total investments. 21. Average round size. 74M. Portfolio companies. 18. Rounds per year. 3.00. Lead investments. 2. Follow on index. 0.14. Exits. 9. Areas of …See details»
Acorn Bioventures - CB Insights
In conjunction with the financing, Isaac Manke (Acorn Bioventures) and Diyong Xu (OrbiMed Advisors) will join the Q32 Bio Board of Directors. The company intends to use the funds to …See details»
ACORN BIOVENTURES, L.P. Top 13F Holdings - WhaleWisdom.com
Acorn Bioventures is based out of New York. Whalewisdom has at least 3 13D filings, and 16 13G filings The firm last filed a Form D notice of exempt offering of securities on 2020-03-27. The …See details»
Acorn Bioventures Information - RocketReach
Acorn Bioventures is based in New York, New York. Top Acorn Bioventures Employees Max Lewin Vice President at Acorn Bioventures New York, NY, US View. 1 gmail.com; Anders …See details»
Acorn Bioventures Fund: Performance - PitchBook
Dec 31, 2020 Acorn Bioventures Fund is a later stage venture capital fund managed by Acorn Bioventures. The fund is based in New York, New York. The fund will invest in …See details»
Acorn Bioventures raises $199.5M for VC fund
Mar 30, 2020 Acorn Bioventures secured approximately $199.5 million for Acorn Bioventures LP. A total of 16 investors committed to the venture capital fund. Acorn is a venture capital firm …See details»
Acorn Bioventures - Contacts, Employees, Board Members
Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies.See details»
Colossal Biosciences Achieves Decacorn Status with $200M Series …
2 days ago Colossal Biosciences, the trailblazer in de-extinction technology, has secured an impressive $200 million in Series C funding, propelling its valuation to decacorn status at …See details»